{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:23:44Z","timestamp":1787772224026,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal organs. Screening these autoantibodies not only aids in the diagnosis but also in predicting specific organ involvement and the risk of complications related to the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study was conducted (a) to study various cutaneous and systemic manifestations of AICTD, (b) to study the antinuclear antibody (ANA) profile and (c) to determine the association between systemic manifestations and antinuclear antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>Thirty cases of autoimmune connective tissue disease were recruited for the study. A physical examination, clinical profile and ANA profile were done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Nonscarring alopecia (83.3%) was the commonest cutaneous manifestation noted, followed by photosensitivity (73.3%). The most common system affected was musculoskeletal (67%), followed by renal (40%). Anti-dsDNA antibodies were significantly associated with musculoskeletal involvement (85%) with a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value of 0.038 and anti-Sm antibodies with neurological involvement (87%), followed by renal involvement (75%) with a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value of 0.018 and 0.001, respectively. Anti-SCL 70 antibodies were significantly associated with lung involvement (75%), with a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value of 0.009 and the presence of anti-SS-A antibodies with cardiovascular involvement (40%) with a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value of 0.014.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Antinuclear antibodies are diagnostic as well as prognostic biomarkers for AICTD and contribute to precision medicine. These antibodies serve as markers to pursue involvement of organs, which in turn helps the treating physician to choose appropriate preventive measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_18_23","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T02:26:16Z","timestamp":1715739976000},"page":"486-490","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Study of Clinical Manifestations and their Association with Antinuclear Antibodies in Various Autoimmune Connective Tissue Disorders"],"prefix":"10.4103","volume":"68","author":[{"given":"Rupa D.","family":"Kondeti","sequence":"first","affiliation":[{"name":"From the Department of D. V. L., Katuri Medical College and Hospital, Guntur, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Venkatesh","sequence":"additional","affiliation":[{"name":"From the Department of D. V. L., Katuri Medical College and Hospital, Guntur, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. V. S. B.","family":"Rama Murthy","sequence":"additional","affiliation":[{"name":"From the Department of D. V. L., Katuri Medical College and Hospital, Guntur, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Kameti","sequence":"additional","affiliation":[{"name":"From the Department of D. V. L., Katuri Medical College and Hospital, Guntur, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sri Devi","sequence":"additional","affiliation":[{"name":"From the Department of D. V. L., Katuri Medical College and Hospital, Guntur, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V.","family":"Chandrika","sequence":"additional","affiliation":[{"name":"From the Department of D. V. L., Katuri Medical College and Hospital, Guntur, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","article-title":"Interstitial lung disease in connective tissue disease - mechanisms and management","volume":"10","author":"Wells","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-4-1","article-title":"Antinuclear antibodies and their detection methods in the diagnosis of connective tissue diseases: A journey revisited","volume":"4","author":"Kumar","year":"2009","journal-title":"Diag Pathol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-2133.2001.04577.x","article-title":"Antibodies targeting extractable nuclear antigens: Historical development and current knowledge","volume":"145","author":"Wenzel","year":"2001","journal-title":"Br J Dermatol"},{"key":"R4-20240829","first-page":"S17","article-title":"International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement","volume":"14","author":"Vitali","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/08916930600886851","article-title":"Cutaneous lupus erythematous: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies","volume":"39","author":"Lee","year":"2006","journal-title":"Autoimmunity"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","article-title":"Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus","volume":"72","author":"Cervera","year":"1993","journal-title":"Medicine (Baltimore)"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma-clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Bes Prac Res Clin Rheumatol"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1191\/0961203306lu2283rr","article-title":"Mixed connective tissue disease","volume":"15","author":"Venables","year":"2006","journal-title":"Lupus"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1177\/0961203312462267","article-title":"Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis","volume":"21","author":"Doria","year":"2012","journal-title":"Lupus"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0377-1237(10)80118-2","article-title":"Correlation between systemic lupus erythematosus disease activity index, C3, C4 and anti-dsDNA antibodies","volume":"66","author":"Narayanan","year":"2010","journal-title":"Med J Armed Forces India"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08916930400022715","article-title":"Anti-Sm and anti-RNP antibodies","volume":"38","author":"Migliorini","year":"2005","journal-title":"Autoimmunity"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.20130","article-title":"Prolongation of the corrected QT interval in adult patients with Anti-Ro\/SSA-positive connective tissue diseases","volume":"50","author":"Lazzerini","year":"2004","journal-title":"Arthritis Rheumatism"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_18_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:32:50Z","timestamp":1787769170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_18_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_18_23","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-01-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}